01304nas a2200277 4500000000100000008004100001260001300042653003300055653003000088653002200118653001100140653001300151653001200164653001500176653001300191653001300204100001800217700001600235700001400251700001600265245010600281300001100387490000700398520060700405022001401012 1989 d c1989 Dec10aDrug Administration Schedule10aDrug Therapy, Combination10aFollow-Up Studies10aHumans10aLepromin10aleprosy10aRecurrence10aRifampin10aSulfones1 aAvelleira J C1 aMarques A B1 aViana F R1 aAndrade V L00a[Efficacy of multidrug therapy in treatment of paucibacillary leprosy patients--preliminary results]. a107-110 v143 a
The efficaciousness evaluation of the polychemotherapics regimens recommended by WHO to the hansenian paucibacillary patients, is carried out mainly by the suitable follow up of patients after therapeutic discharge. The criterion for inclusion of patients as paucibacillary ones is another point of importance. The authors based on the follow up of 66 patients that completed treatment and in the absence of relapses until the moment, advise that together with the clinical classification it should be considered factors like: the Mitsuda test, the number of lesions and the bacilloscopy result.
a0100-3283